2025 mein 4 Penny Stocks 100% se zyada badhe, Nifty ko piche chhoda

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
2025 mein 4 Penny Stocks 100% se zyada badhe, Nifty ko piche chhoda
Overview

Indian markets ne 2025 mein 10.7% gain ke saath Nifty ki 10 saal ki winning streak maintain ki, par domestic aur global challenges ke karan peers se piche reh gaye. Is beech, Rs 100 se kam wale 4 penny stocks ne zabardast returns diye, jisme Shukra Pharma ne strong financial results aur robotics MoU se 314% surge dikhaya. GRM Overseas, AB Infrabuild, aur Arfin India ne bhi FII interest, corporate actions, aur major orders ke karan 100% se zyada gains post kiye.

Nifty ne Global Headwinds ke beech 2025 mein Modest Gains kiye

Indian equity markets ne 2025 ko benchmark Nifty ki dasvi lagatar saal ki badhotri ke saath band kiya, jo ki 10.7% rahi. Saal ko tez badhotri ke bajaye resilience se pehchana gaya, kyunki gharelu chunautiyon aur global economic dabavon ne Indian equities ko kai international aur emerging market peers se peeche chhod diya. Bazaar ke is kamzor performance ke bawajood, chote companiyon ke ek chune hue group ne exceptional returns diye.

Shukra Pharma ne Penny Stock Rally ko Lead kiya

Shukra Pharma, ek pharmaceutical manufacturer, 2025 mein 314% ke zabardast rally ke saath ek standout performer bana. Iske stock price mein January 1 ko ₹14.3 se badhkar December 31 tak ₹59.3 ho gaya. Yeh surge strong year-on-year financial improvements se tej hua, jisme June quarter revenue lagbhag 69% badha aur net profit dugna ho gaya. September quarter ne bhi mahatvapurn profit growth ke saath trend jari rakha. Investor confidence ko aur badhane ke liye, Shukra Pharma ki subsidiary ne US-based Borns Medical Robotics Inc. ke saath ek MoU sign kiya hai, jiske tahat India aur select South Asian markets mein AI-enabled surgical robotic systems introduce kiye jayenge.

GRM Overseas ne FIIs ko Aakarshit kiya aur Bonus Declare kiya

GRM Overseas, ek basmati rice miller aur marketer, ne 2025 mein 143% ka stock price jump dekha, jo ₹66.73 se ₹162.1 tak pahuncha. Foreign Institutional Investors (FIIs) ne saal bhar mein apna stake kafi badhaya, jo 0.17% se 3.36% tak pahunch gaya. Company ke board ne December 2025 mein 2:1 bonus share issue ko bhi manzoori di. GRM Overseas ne substantial revenue growth ka anuman lagaya hai, jisme uska India business revenue FY25 mein ₹5.4 billion se badhkar FY28 tak ₹20 billion hone ki ummeed hai.

AB Infrabuild ne Important Infrastructure Orders Secure kiye

Railways, roads, aur dams ke liye civil construction mein lagi AB Infrabuild ke stock ne 2025 mein 107% ka gain kiya, ₹8.6 se ₹17.9 tak pahuncha. Company ne stock split execute kiya, jisme share face value ₹10 se ₹1 tak kam ho gaya. East Coast Railways, Indian Railways se ₹520.8 million ka ek mahatvapurn domestic order, jise 24 mahino mein execute kiya jayega, ne iske prospects ko aur mazboot kiya. Company apne operational reach aur capabilities ko badhane par focus kar rahi hai.

Arfin India ne Major Metals Order Jeeta

Arfin India, ek non-ferrous metals manufacturer, ne 2025 mein 104% ka gain post kiya, iska stock price ₹35.9 se ₹73.3 tak pahuncha. FIIs ne September quarter mein company mein 0.2% stake add kiya. December 2025 mein, Arfin India ne Diamond Power Infrastructure Limited se ₹3,210 million ka ek substantial order jeeta hai, jo aluminium conductors ke liye hai aur isme 11 mahino mein 11,000 metric tonnes ki supply shamil hai. Company capacity expansion aur new product launches ki planning kar rahi hai.

Penny Stock Investors ke liye Caution Jaruri

Halanki in penny stocks ne exceptional returns diye hain, sirf pichle performance ke aadhar par in mein invest karna substantial risk deta hai. Inki high volatility, potential lack of liquidity, aur kamzor financial fundamentals inhe speculative banate hain. Investors ko salah di jati hai ki woh thorough due diligence ko priority dein, company fundamentals, corporate governance, aur valuations ko examine karein, aur long-term wealth creation ke liye diversified portfolios par vichar karein.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.